Sprout Pharmaceuticals was acquired by Valeant in 2015 for $1 billion, just days after the Food and Drug Administration approved its first drug, Addyi.
Sprout Pharmaceuticals was acquired by Valeant in 2015 for $1 billion, just days after the Food and Drug Administration approved its first drug, Addyi. Harry Lynch hlynch@newsobserver.com
Sprout Pharmaceuticals was acquired by Valeant in 2015 for $1 billion, just days after the Food and Drug Administration approved its first drug, Addyi. Harry Lynch hlynch@newsobserver.com

Sprout shareholders get their female libido pill back from Valeant

November 06, 2017 05:44 PM